Physicists, oncologists, radiotherapists and radiographers explored “The future of molecular radiotherapy” which was the topic of the Internal Dosimetry Users Group (IDUG) this summer.
This was a joint event between IDUG and the BIR and organised in conjunction with co-founder of IDUG Daniel McGowan. The day covered molecular radiotherapy (MRT) dosimetry trials, radium treatments and an overview of what’s coming up in the future for treatments and software.
Now established as a biennial event, the programme followed on from the joint conference in 2014 and once again received excellent feedback, with delegates noting the great opportunity to network and to explore new technologies and innovations with industry representatives. Participants had the opportunity to view poster presentations, with many from contributors from Europe.
Highlights of the event included an overview of 1-131 trials with different perspectives from a physicist (Rebecca Gregory) and an oncologist (Dr Jon Wadsley) and a fascinating insight into 3D printed phantoms by Dr Andrew Robinson. Allison Craig gave a very popular talk on the “Working party for the implementation of dosimetry in molecular radiotherapy”.
Many delegates commented on the good mix and breadth of both scientific and clinical perspectives and the opportunity to mix with colleagues from different settings. As one participant commented “A very inspiring and necessary meeting. I learnt a lot!”
The next IDUG meeting will take place in June 2018 in Oxford.
Photo (left to right): Bruno Rojas, Jon Wadsley, Rebecca Gregory, Antti Sohlberg, Allison Craig, Mark Gooding, Alan Nahum, Andrew Robinson, Daniel McGowan, Knut Liepe, Matt Guy, Jill Tipping, Michael Tapner
